Knight Therapeutics | GUD - Ebit

股票价格

7.55

每天变化

-0.10 -1.31%

每月一次

21.97%

每年

35.06%

Q2 预测

7.37

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD -0.09

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 771.93M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	Ebit	更改		日
Acasti Pharma	USD -3.7M		1.13M	2024-12
Akebia Therapeutics	USD -5.45M		9.4M	2025-12
Alaunos Therapeutics	USD -1.19M		148K	2025-09
Aurora Cannabis	CAD -35.79M		8.96M	2025-12
Avita Medical	AUD -10.39M		1.72M	2025-12
Canopy Growth	CAD -12.66M		1.64M	2025-12
Cronos Group	USD -7.06M		62.31M	2025-12
Dianthus Therapeutics	USD -69.54M		29.25M	2025-12
Ionis Pharmaceuticals	USD -215M		54.82M	2025-12
IQVIA Holdings	USD 2.68B		2.1B	2025-12
Knight Therapeutics	CAD 6.21M		3.27M	2025-12
Moderna	USD -857M		597M	2025-12
Omeros	USD -48.15M		7.25M	2023-09
Organigram Holdings	CAD -20.13M		7.92M	2025-12
Organon & Co	USD 388M		28M	2025-09
Revvity	USD 145.83M		47.49M	2025-12
Tectonic Therapeutic	USD -21.52M		374K	2025-12
Tilray	USD -20.01M		9.34M	2025-09
Viatris	USD -157.5M		392M	2025-12
Xeris Pharmaceuticals	USD 16.77M		8.88M	2025-12